The best Bull and Bear pitches based on recency and number of recommendations.
This company has created a new business plan to have this medication authorized by the insurance companies at the home office of INSY and taken it out of the hands of the perscribing physicians. This has enabled the company to have more… More
This is a rising knife stock if ever there was one, so don't expect this to be a real world position any time soon. More than 99% of Insys revenues come from a single drug, Subsys, which is a sublingual spray of the potent opiate fentanyl. If… More
Read the most recent pitches from players about INSYQ.
Recs
The focus on CBD related medicines will eventually propel this stock.
Recs
Based on "flopped" earnings and no new products slated till later in the year.
Recs
The company, which is already highly profitable, is ready to release a THC medication marketed as an alternative to Marinol. Trials have shown that it is tolerated far better by patients than Marinol.
Find the members with the highest scoring picks in INSYQ.
armycommando (80.02) Score: +274.96
The Score Leader is the player with the highest score across all their picks in INSYQ.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
armycommando | 80.02 | 4/16/2014 | 5Y | $18.66 | -98.44% | +176.52% | +274.96 | 0 Comment | ||
CocaineOrStock | 87.07 | 7/15/2014 | 5Y | $12.79 | -97.72% | +159.89% | +257.62 | 0 Comment | ||
barrywstone | 40.09 | 7/29/2014 | NS | $14.63 | -98.01% | +158.80% | +256.81 | 0 Comment | ||
whatthree16 | 66.59 | 12/4/2014 | 5Y | $19.07 | -98.47% | +147.11% | +245.59 | 0 Comment | ||
carmendarez | < 20 | 12/22/2016 | 5Y | $9.26 | -96.86% | +127.33% | +224.19 | 0 Comment | ||
chushogi | 54.53 | 12/13/2016 | 5Y | $9.17 | -96.83% | +125.91% | +222.74 | 0 Comment | ||
AriGold212855 | < 20 | 5/12/2017 | 1Y | $11.74 | -97.52% | +114.67% | +212.19 | 1 Comment | ||
divingfalcon | < 20 | 6/12/2017 | 5Y | $11.35 | -97.44% | +110.94% | +208.38 | 0 Comment | ||
OttoBismarck | 98.71 | 12/18/2018 | 5Y | $4.30 | -93.23% | +101.14% | +194.37 | 0 Comment | ||
airenInDebt | 82.51 | 9/17/2018 | 1Y | $8.44 | -96.55% | +76.35% | -172.90 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.